Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
2
×
Tags
biotech
2
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
cell therapy
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
investing
2
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
2
×
spark therapeutics
texas blog main
texas top stories
venture capital
2
×
vertex pharmaceuticals
wisconsin blog main
wisconsin top stories
abeona therapeutics
accent therapeutics
achilles therapeutics
acute myeloid leukemia
akouos
What
bio
roundup
advantages
ahead
asco
bar
branded
brings
choices
commissioner
consumers
costly
counterweight
drug
drugs
elevatebio
expect
fda
gamble
generic
graft
market
medco’s
medications
mover
new
patients
payers
physicians
plan
pricing
rises
sets
supposed
tenure
type
ubiome
undone
vertex’s
Language
unset
Current search:
investing
×
photo
×
" venture capital "
×
biotech
×
" seattle top stories "
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
